Imagine: A World With
Control Over Chronic
Respiratory Disease

4 million people die prematurely from chronic respiratory disease each year1. We develop solutions that empower patients to take charge of their respiratory health and more.

Our Solutions

A.I. powered wearable stethoscope recording and analyzing lung sounds to detect early signs of chronic respiratory disease exacerbation remotely.

Find Out More

Smart wearable for kids tracking their respiratory rate and heart rate through the night

Find Out More

Learn more about the science behind our technology.

Chronic Respiratory Disease is Pervasive and Costly

Asthma

Asthma is a disease causing airways to become inflamed and narrow. It is the most common chronic condition among children.

339M

  • in the world affected by Asthma2.

>US$3K

  • spent per patient in the USA due to Asthma3.

1,300

  • deaths per day due to Asthma1.

>US$3K

  • spent per patient in the USA due to Asthma3.

14%

  • of children suffer from Asthma globally1.

COPD

Chronic Obstructive Pulmonary Disease
(COPD) is a group of diseases that limit airflow to lungs. It is a long-term disease that gradually worsens over time.

210M

  • in the world affected by COPD4.

US$316K

  • average lifetime earnings losses per individual due to premature retirement5.

3rd

  • leading cause of death by 20301.

>72%

  • underdiagnosed globally1.

Chronic Respiratory Disease is Difficult to Manage

%

of patients do not consult
the GP
despite experiencing
bronchial symptoms6.

%

of patients diagnosed with asthma do not adhere to treatment plans7.

%

of patients above 65 years old unable to perform a valid spirometry test, complicating COPD diagnoses8.

How We Can Help

Our scalable and cost effective patient-centered solutions address unique needs of stakeholders.

Patients

  • Improve treatment adherence by visualizing response to treatment plan.
  • Reduce healthcare costs by enabling management of disease from home.
  • Personalize experience to optimize engagement with healthcare providers.

Pharmaceutical Companies

  • Provide real-world evidence in drug development and commercialization.
  • Optimize recruitment and retention for trials through remote data collection.
  • Increase value-based payments through patient-centred endpoints.

Healthcare Providers

  • Deliver value-based care with improved patient-reported outcomes.
  • Increase patient engagement and improve communication.
  • Streamline diagnosis and treatment for effective and efficient care.

Payers

  • Reduce readmissions in hospitals and overall healthcare expenditure.
  • Facilitate self-management of chronic respiratory disease from home.
  • Drive risk stratification to identify unique needs to personalize patient experience.

Payers

  • Reduce readmissions in hospitals and overall healthcare expenditure.
  • Facilitate self-management of chronic respiratory disease from home.
  • Drive risk stratification to identify unique needs to personalize patient experience.

Healthcare Providers

  • Deliver value-based care with improved patient-reported outcomes.
  • Increase patient engagement and improve communication.
  • Streamline diagnosis and treatment for effective and efficient care.

Partners

Investors

Press & Media

Aevice Health awarded Seed Grant from HealthTEC Singapore

Singapore, January 14, 2021 – Aevice Health, a Singapore-based MedTech company at the forefront of addressing chronic respiratory disease, today announced that it has been awarded the HealthTEC Seed Grant from HealthTEC Singapore. The grant would see Aevice Health working towards… (Read More)

Aevice Health receives ISO 13485:2016 Certification

Singapore, November 19, 2020 – Aevice Health, a MedTech company developing wearables for chronic respiratory disease patients, announced today that it has been awarded ISO 13485:2016 certification for Medical Device and Quality Management Systems (QMS) from TÜV SÜD… (Read More)

Let’s Connect

We’d love to share more about our solutions.
References
  1. Forum of International Respiratory Societies. The Global Impact of Respiratory Disease. 2nd ed. 2017. https://www.who.int/gard/publications/The_Global_Impact_of_Respiratory_Disease.pdf.
  2. World Health Organisation. “Asthma.” 2020. https://www.who.int/news-room/fact-sheets/detail/asthma.
  3. Dierick, Boudewijn J.H., Thys Van Der Molen, Bertine M.J. Flokstra-de Blok, Antonella Muraro, Maarten J. Postma, Janwillem W.H. Kocks, and Job F.M. Van Boven. “Burden and Socioeconomics of Asthma, Allergic Rhinitis, Atopic Dermatitis and Food Allergy.” Expert Review of Pharmacoeconomics & Outcomes Research, 2020, 437-53. doi:10.1080/14737167.2020.1819793.
  4. World Health Organisation. Global Surveillance, Prevention and Control of Chronic Respiratory Diseases: A Comprehensive Approach. 2007. https://www.who.int/gard/publications/GARD Book 2007.pdf?ua=1.
  5. Fletcher, Monica J., Jane Upton, Judith Taylor-Fishwick, Sonia A. Buist, Christine Jenkins, John Hutton, Neil Barnes, Thys Van Der Molen, John W. Walsh, Paul Jones, and Samantha Walker. “COPD Uncovered: An International Survey on the Impact of Chronic Obstructive Pulmonary Disease [COPD] on a Working Age Population.” BMC Public Health, 2011. doi:10.1186/1471-2458-11-612.
  6. Aaron, Shawn D., Louis Phillippe Boulet, Helen K. Reddel, and Andrea S. Gershon. “Underdiagnosis and Overdiagnosis of Asthma.” American Journal of Respiratory and Critical Care Medicine, 2018, 1012-020. doi:10.1164/rccm.201804-0682CI.
  7. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2020. https://ginasthma.org/wp-content/uploads/2020/04/GINA-2020-full-report_-final-_wms.pdf.
  8. Hangaard, Stine, Tina Helle, Carl Nielsen, and Ole K. Hejlesen. “Causes of Misdiagnosis of Chronic Obstructive Pulmonary Disease: A Systematic Scoping Review.” Respiratory Medicine, 2017, 63-84. doi:10.1016/j.rmed.2017.05.015.
This is Aevice
Our Solutions
Legal

Privacy & Terms

Resources
Contact Us
ISO13485 Certified

Copyright © 2021 Aevice Health. All rights reserved.
ISO13485 Certified